Skip Navigation


The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients.

Bookmark | Print | E-Mail

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic e-mail notifications as soon as a clinical trial is posted in the medical category you're interested in.






Home » Drug Information » FDA-Approved Drugs » 1997
Medical Areas: Neurology

View By: Year Company Therapeutic Areas Drug Names 

Drug Information

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Drug Name: NORCO tablets (Hydrocodone Bitartrate/Acetaminophen 10 mg/325 mg)

Company: Watson Pharmaceuticals
Approval Status: Approved February 1997
Treatment Area: moderate pain

General Information

NORCO tablets (Hydrocodone Bitartrate/Acetaminophen 10 mg/325 mg) have been approved for the treatment of moderate pain. NORCO is the highest single tablet dose of Hydrocodone Bitartrate with the lowest level of Acetaminophen of all 10 mg Hydrocodone combination products indicated for the relief of moderate to moderately severe pain.


Jobson Medical Information

Copyright © 1995-2009 Jobson Medical Information LLC.


Designed by Piehead Productions LLC.